TIAA CREF INVESTMENT MANAGEMENT LLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 63 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q1 2017$180,000
-20.0%
54,542
-3.2%
0.00%
Q4 2016$225,000
-39.5%
56,324
-11.0%
0.00%
Q3 2016$372,000
+7.5%
63,2850.0%0.00%
Q2 2016$346,00063,2850.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q4 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 10,000$13,0000.01%
Stone Ridge Asset Management LLC 30,698$41,0000.00%
WEDBUSH SECURITIES INC 13,500$18,0000.00%
Westside Investment Management, Inc. 2,889$4,040,0000.00%
Wealthspire Advisors, L.P. 11,708$16,0000.00%
Blume Capital Management, Inc. 2,546$3,0000.00%
American Portfolios Advisors 2,729$3,6160.00%
Renaissance Technologies 552,200$732,0000.00%
ROYAL BANK OF CANADA 18$00.00%
UBS Group AG 237$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders